CypRules statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.

Subscribe
info

Citations per year

Citations chart
info

Popular tool citations

chevron_left Drug metabolism chevron_right
Popular tools chart
info

Tool usage distribution map

Tool usage distribution map
info

Associated diseases

Associated diseases

CypRules specifications

Information


Unique identifier OMICS_07388
Name CypRules
Interface Web user interface
Restrictions to use None
Computer skills Basic
Stability Stable
Maintained Yes

Maintainer


  • person_outline Yufeng J. Tseng <>

Publication for CypRules

CypRules in publication

PMCID: 5556109
PMID: 28808272
DOI: 10.1038/s41598-017-08404-0

[…] cyp2d6 inhibition have been published recently–, . however, these in silico platforms have not been used to prospectively identify and biologically test new inhibitors. one of these platforms, cyprules, is publicly available., when tested with our newly found inhibitors and the compounds that were inactive in the cyp2d6 in vitro assay, 62% of the active and 83% of the inactive compounds […]


To access a full list of publications, you will need to upgrade to our premium service.

CypRules institution(s)
Graduate Institute of Biomedical Electronics and Bioinformatics and Department of Computer Science and Information Engineering, National Taiwan University, Taipei, Taiwan

CypRules reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review CypRules